| For: | Masoud V, Pagès G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol 2017; 8(2): 120-134 [PMID: 28439493 DOI: 10.5306/wjco.v8.i2.120] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i2/120.htm |
| Number | Citing Articles |
| 1 |
Lisa König, Fabian D. Mairinger, Oliver Hoffmann, Ann-Kathrin Bittner, Kurt W. Schmid, Rainer Kimmig, Sabine Kasimir-Bauer, Agnes Bankfalvi. Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5320-2
|
| 2 |
Xiao Jian Tan, Wai Loon Cheor, Ee Meng Cheng, Khairul Shakir Ab Rahman, Wan Zuki Azman Wan Muhamad, Wai Zhe Leow. Breast cancer status, grading system, etiology, and challenges in Asia: an updated review. Oncologie 2023; 25(2) doi: 10.1515/oncologie-2022-1011
|
| 3 |
Anwar Shams. Impact of prolactin treatment on enhancing the cellular responses of MCF7 breast cancer cells to tamoxifen treatment. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01701-x
|
| 4 |
K. Pather, T. N. Augustine. Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75779-y
|
| 5 |
Nemany A.N. Hanafy. Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer. International Journal of Biological Macromolecules 2021; 182 doi: 10.1016/j.ijbiomac.2021.05.149
|
| 6 |
Yiyuan Feng, Caiying He, Chang Liu, Bingjie Shao, Dong Wang, Peijie Wu. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development. International Journal of Molecular Sciences 2024; 25(12) doi: 10.3390/ijms25126444
|
| 7 |
Laura Lacerda Coelho, Matheus Menezes Vianna, Debora Moraes da Silva, Beatriz Matheus de Souza Gonzaga, Roberto Rodrigues Ferreira, Ana Carolina Monteiro, Adriana Cesar Bonomo, Pedro Paulo de Abreu Manso, Marcelo Alex de Carvalho, Fernando Regla Vargas, Luciana Ribeiro Garzoni. Spheroid Model of Mammary Tumor Cells: Epithelial–Mesenchymal Transition and Doxorubicin Response. Biology 2024; 13(7) doi: 10.3390/biology13070463
|
| 8 |
Ching-Hsuan Liu, Sy-Jye Leu, Chi-Hsin Lee, Cheng-Yuan Lin, Wei-Chu Wang, Bor-Yu Tsai, Yu-Ching Lee, Chi-Long Chen, Yi-Yuan Yang, Liang-Tzung Lin. Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1292019
|
| 9 |
Limei Yuan, Yaqing Zhu, Gege Guan, Mei Liu. Napabucasin targets resistant triple negative breast cancer through suppressing STAT3 and mitochondrial function. Cancer Chemotherapy and Pharmacology 2025; 95(1) doi: 10.1007/s00280-025-04770-z
|
| 10 |
Marina Petrenko, Antje Güttler, Anne Funtan, Jacqueline Keßler, Daniel Emmerich, Reinhard Paschke, Dirk Vordermark, Matthias Bache. Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells. Chemico-Biological Interactions 2021; 333 doi: 10.1016/j.cbi.2020.109326
|
| 11 |
Tong Sun, Reza Golestani, Haiying Zhan, Uma Krishnamurti, Malini Harigopal, Minghao Zhong, Yuanxin Liang.
Clinicopathologic Characteristics of
MYC
Copy Number Amplification in Breast Cancer
. International Journal of Surgical Pathology 2025; 33(1) doi: 10.1177/10668969241256109
|
| 12 |
Joel Vidal Verdaguer, Robert Martí Marly, Hilde Bosmans, Nicholas Marshall, Chantal Van Ongeval. Using deep learning for triple-negative breast cancer classification in DCE-MRI. 16th International Workshop on Breast Imaging (IWBI2022) 2022; doi: 10.1117/12.2625780
|
| 13 |
S. Krajnak, C. Schnatz, K. Almstedt, W. Brenner, F. Haertner, A.-S. Heimes, A. Lebrecht, G.-M. Makris, R. Schwab, A. Hasenburg, M. Schmidt, M. J. Battista. Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study. Breast Cancer Research and Treatment 2020; 182(2) doi: 10.1007/s10549-020-05711-5
|
| 14 |
Yogita Chhichholiya, Prabhat Suman, Sandeep Singh, Anjana Munshi. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies. Medical Oncology 2021; 38(8) doi: 10.1007/s12032-021-01547-1
|
| 15 |
Eugena Stamuli, Sorcha Corry, Derek Ross, Thomais Konstantopoulou, Luis Texeira, Bernard Avouac, Dominique Debiais, Liz Yates, Arni Behis, Ambrose McLoughlin, Federacja Stowarzyszeń Amazonki, Maciej Niewada, Ana Casas, Jaime Espin. Patient Preferences for Breast Cancer Treatments: A Discrete Choice Experiment in France, Ireland, Poland and Spain. Future Oncology 2022; 18(9) doi: 10.2217/fon-2021-0635
|
| 16 |
Zinelabedin Mohamed, Alqasim Abdulkarim, Ahmed R. Abdullah, Mohammed Al-Azab, Mohamed Baklola. Molecular subtypes of breast cancer in Libyan women and their clinicopathological associations: A retrospective observational study from eastern Libya. Medicine 2026; 105(13) doi: 10.1097/MD.0000000000048215
|
| 17 |
|
| 18 |
Cheng Zhang, Jiao‐jiao Yu, Chen Yang, Shuang Shang, Xiao‐xi Lv, Bing Cui, Fang Hua. Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses. Cancer Innovation 2022; 1(1) doi: 10.1002/cai2.7
|
| 19 |
Eun Jung Sohn, Deok-Beom Jung, HyoJung Lee, Ihn Han, Jihyun Lee, Hyemin Lee, Sung-Hoon Kim. CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells. Cancer Letters 2018; 412 doi: 10.1016/j.canlet.2017.09.052
|
| 20 |
Kyaw Zin Thein, Thura Win Htut, Somedeb Ball, Sriman Swarup, Anita Sultan, Thein Hlaing Oo. Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Research and Treatment 2020; 183(2) doi: 10.1007/s10549-020-05783-3
|
| 21 |
Kanika Verma, Panupong Mahalapbutr, Atima Auepattanapong, Onnicha Khaikate, Chutima Kuhakarn, Kaito Takahashi, Thanyada Rungrotmongkol. Molecular dynamics simulations of sulfone derivatives in complex with DNA topoisomerase IIα ATPase domain. Journal of Biomolecular Structure and Dynamics 2022; 40(4) doi: 10.1080/07391102.2020.1831961
|
| 22 |
Bárbara Costa, Irina Amorim, Fátima Gärtner, Nuno Vale. Understanding Breast cancer: from conventional therapies to repurposed drugs. European Journal of Pharmaceutical Sciences 2020; 151 doi: 10.1016/j.ejps.2020.105401
|
| 23 |
Haixia Zhang. Exploring Herbal Compounds as Targeted Therapies for Breast Cancer: Insights from Network Pharmacology, Molecular Docking, MD Simulation, ADME-Toxicity and DFT Profiles. Iranian Journal of Pharmaceutical Research 2024; 23(1) doi: 10.5812/ijpr-153579
|
| 24 |
Alex Ap. Rosini Silva, Marcella R. Cardoso, Danilo Cardoso de Oliveira, Pedro Godoy, Maria Cecília R. Talarico, Junier Marrero Gutiérrez, Raquel M. Rodrigues Peres, Lucas M. de Carvalho, Natália Angelo da Silva Miyaguti, Luis O. Sarian, Alessandra Tata, Sophie F. M. Derchain, Andreia M. Porcari. Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 2024; 16(13) doi: 10.3390/cancers16132473
|
| 25 |
Winfrey Pui Yee Hoo, Pui Yan Siak, Lionel L.A. In. Overview of Current Immunotherapies Targeting Mutated KRAS Cancers. Current Topics in Medicinal Chemistry 2019; 19(23) doi: 10.2174/1568026619666190904163524
|
| 26 |
PalashKumar Mandal, Anindya Adhikari, Subir Biswas, Amita Giri, Arnab Gupta, Arindam Bhattacharya. Comparison of histopathological grading and staging of breast cancer with p53-positive and transforming growth factor-beta receptor 2-negative immunohistochemical marker expression cases. Cancer Translational Medicine 2020; 6(2) doi: 10.4103/ctm.ctm_4_20
|
| 27 |
Mohini Guleria, Rohit Sharma, Jeyachitra Amirdhanayagam, Haladhar D. Sarma, Venkatesh Rangarajan, Ashutosh Dash, Tapas Das. Formulation and clinical translation of [177Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer. RSC Medicinal Chemistry 2021; 12(2) doi: 10.1039/D0MD00319K
|
| 28 |
Wajana Lako LABISSO. Status of Pathology Services and Molecular Pathology in Sub-Saharan Africa: Implications for Combating Breast Cancer. Korean Journal of Clinical Laboratory Science 2023; 55(3) doi: 10.15324/kjcls.2023.55.3.121
|
| 29 |
Baha’ Sharaf, Abdelrahman Hajahjeh, Hira Bani Hani, Hikmat Abdel-Razeq. Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1385577
|
| 30 |
Sho Ueno, Min Woo Kim, Gibok Lee, Yong Il Park, Takuro Niidome, Ruda Lee. Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics 2020; 12(6) doi: 10.3390/pharmaceutics12060585
|
| 31 |
Avia D. Wilkerson, Corey K. Gentle, Camila Ortega, Zahraa Al-Hilli. Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity. Healthcare 2024; 12(4) doi: 10.3390/healthcare12040462
|
| 32 |
Cijo George Vazhappilly, Rawad Hodeify, Shoib Sarwar Siddiqui, Amina Jamal Laham, Varsha Menon, Raafat El‐Awady, Rachel Matar, Maxime Merheb, John Marton, Hussain Abdel Karim Al Zouabi, Rajan Radhakrishnan. Natural compound catechol induces DNA damage, apoptosis, and G1 cell cycle arrest in breast cancer cells. Phytotherapy Research 2021; 35(4) doi: 10.1002/ptr.6970
|
| 33 |
Tomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, Nikola Zmarzły, Dariusz Boroń, Piotr Ossowski, Olga Nowotny-Czupryna, Kacper Boroń, Dominika Janiszewska-Bil, Elżbieta Mitka-Krysiak, Beniamin Oskar Grabarek. Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1515387
|
| 34 |
Sunny Gupta, Shipra Gupta, Manju Singh, Ashok Kumar Patel. Anticancer potential of exosome-like nanoparticles isolated from Acorus calamus in breast cancer. 3 Biotech 2025; 15(6) doi: 10.1007/s13205-025-04349-8
|
| 35 |
Mohammad Tabrizi, Daping Zhang, Vaishnavi Ganti, Glareh Azadi. Integrative Pharmacology: Advancing Development of Effective Immunotherapies. The AAPS Journal 2018; 20(4) doi: 10.1208/s12248-018-0229-2
|
| 36 |
Constantinos Demetriou, Naila Abid, Michael Butterworth, Larissa Lezina, Pavandeep Sandhu, Lynne Howells, Ian R. Powley, James H. Pringle, Zahirah Sidat, Omar Qassid, Dave Purnell, Monika Kaushik, Kaitlin Duckworth, Helen Hartshorn, Anne Thomas, Jacqui A. Shaw, Marion MacFarlane, Catrin Pritchard, Gareth J. Miles. An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-63170-0
|
| 37 |
Nakka Sharmila Roy, Mamta Kumari, Kamare Alam, Anamitra Bhattacharya, Santanu Kaity, Kulwinder Kaur, Velayutham Ravichandiran, Subhadeep Roy. Development of bioengineered 3D patient derived breast cancer organoid model focusing dynamic fibroblast–stem cell reciprocity. Progress in Biomedical Engineering 2025; 7(1) doi: 10.1088/2516-1091/ad9dcb
|
| 38 |
Uzma Ghaffar, Faizullah Khan, Javid Hussain, Suraj N. Mali, Ajmal Khan, Somdatta Y. Chaudhari, Rahul D. Jawarkar, Abdullah K. Alanazi, Waseem Ul Islam, Mostafa A. Ismail, Ahmed Al-Harrasi, Zahid Shafiq. In-vitro and in-silico study to assess anti breast cancer potential of N-tosyl-indole based hydrazones. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-21326-6
|
| 39 |
Jenny M. Hogstrom, Kayla A. Cruz, Laura M. Selfors, Madelyn N. Ward, Tejas S. Mehta, Naama Kanarek, Jordana Philips, Vandana Dialani, Gerburg Wulf, Laura C. Collins, Jaymin M. Patel, Taru Muranen. Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms. Journal of Biological Chemistry 2023; 299(8) doi: 10.1016/j.jbc.2023.105021
|
| 40 |
Vítor Yang, Maria João Gouveia, Joana Santos, Beate Koksch, Irina Amorim, Fátima Gärtner, Nuno Vale. Breast cancer: insights in disease and influence of drug methotrexate. RSC Medicinal Chemistry 2020; 11(6) doi: 10.1039/D0MD00051E
|
| 41 |
Xing Ke, Lisong Shen. Molecular targeted therapy of cancer: The progress and future prospect. Frontiers in Laboratory Medicine 2017; 1(2) doi: 10.1016/j.flm.2017.06.001
|
| 42 |
Duna H. Barakeh, Rasha Aljelaify, Yara Bashawri, Amal Almutairi, Fatimah Alqubaishi, Mohammed Alnamnakani, Latifa Almubarak, Abdulrahman Al Naeem, Fatema Almushawah, May Alrashed, Malak Abedalthagafi. Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients. Oncotarget 2021; 12(7) doi: 10.18632/oncotarget.27909
|
| 43 |
Molly M Morgan, Linda A Schuler, Jordan C Ciciliano, Brian P Johnson, Elaine T Alarid, David J Beebe. Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro. Integrative Biology 2020; 12(2) doi: 10.1093/intbio/zyaa002
|
| 44 |
Gautam Kumar, Farmiza Begum, Prasada Chowdari Gurram, Bharath H. B., Prashansha Mullick, Krishnadas Nandakumar, Srinivas Mutalik, Chamalamudi Mallikarjuna Rao. Enhanced Anticancer Activity in HR +/HER2 + Breast Cancer Cells Using Trastuzumab-Conjugated Liposomes co-loaded with siRNA and Tamoxifen. BioNanoScience 2025; 15(4) doi: 10.1007/s12668-025-02149-1
|
| 45 |
Subhrasima Nayak, Arka Karmakar, Lalit Kumar. Emerging Trends in Cancer Research. 2026; doi: 10.1016/B978-0-443-43870-7.00015-1
|
| 46 |
Yinji Cui, Meiying Song, Su Young Kim. Prognostic significance of fatty acid binding protein‐4 in the invasive ductal carcinoma of the breast. Pathology International 2019; 69(2) doi: 10.1111/pin.12756
|
| 47 |
Rui-Zhi Tang, Zhen-Zhen Liu, Sai-Sai Gu, Xi-Qiu Liu. Multiple local therapeutics based on nano-hydrogel composites in breast cancer treatment. Journal of Materials Chemistry B 2021; 9(6) doi: 10.1039/D0TB02737E
|
| 48 |
Mai G. Awad, Nemany A. N. Hanafy, Ramadan A. Ali, Dalia D. Abd El‑Monem, Sara H. El-Shafiey, Mohammed A. El‑Magd. Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers. Cancer Nanotechnology 2024; 15(1) doi: 10.1186/s12645-024-00297-9
|
| 49 |
Deborah O. Onwusah, Elizabeth B. Ojewole, Moses J. Chimbari. Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review. JCO Global Oncology 2023; (9) doi: 10.1200/GO.21.00289
|
| 50 |
Christian Rafael Quijia, Andreina Quevedo Enríquez, Carlos Daniel Zappia, Roxana Noemí Peroni, Marlus Chorilli. Administration of Inhibitory Molecules through Nanoparticles in
Breast Cancer Therapy. Current Medicinal Chemistry 2024; 31(6) doi: 10.2174/0929867330666230608145125
|
| 51 |
Min-Gu Lee, Hyun-Jin Hong, Kyung-Soo Nam. Anthocyanin Oligomers Induce Apoptosis and Autophagy by Inhibiting the mTOR Signaling Pathway in Human Breast Cancer Cells. Pharmaceuticals 2023; 17(1) doi: 10.3390/ph17010024
|
| 52 |
Huayan Ren, Xiaoyi Mi, Pengyuan Zhao, Xueyan Zhao, Na Wei, Huifen Huang, Zhongqin Meng, Junna Kou, Mingfang Sun, Yuqiong Liu, Hongyan Zhang, Jianping Yang, Wencai Li, Huixiang Li. TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin. Breast Cancer Research and Treatment 2020; 183(2) doi: 10.1007/s10549-020-05789-x
|
| 53 |
Nishant Kumar, Md Sadique Hussain, Prince Ahad Mir, Adil Farooq Wali, Sameer Ullah Khan, Roohi Mohi-ud-din, Imran Rangraze, Shahzada Mudasir Rashid, Reyaz Hassan Mir. Cell Signaling Pathways and Their Therapeutic Implication in Cancers. 2025; doi: 10.1007/978-981-96-2763-9_4
|
| 54 |
Ashok Thulluru, Goutham Yerrakula, Nawaz Mohammed, Reshma Tadipatri, Varun Srighakollapu. Genomics and Precision Healthcare. 2026; doi: 10.1002/9781394367559.ch3
|
| 55 |
Yanamandala Nitheesh, Rajesh Pradhan, Siddhant Hejmady, Rajeev Taliyan, Gautam Singhvi, Amit Alexander, Prashant Kesharwani, Sunil Kumar Dubey. Surface engineered nanocarriers for the management of breast cancer. Materials Science and Engineering: C 2021; 130 doi: 10.1016/j.msec.2021.112441
|
| 56 |
Emmanuel Ifeanyi Obeagu. Neutrophil-driven tumor inflammation in breast cancer: Pathways and therapeutic implications: A narrative review. Medicine 2025; 104(25) doi: 10.1097/MD.0000000000043024
|
| 57 |
Carmen Chan, Bernard Law, Winnie So, Ka Chow, Mary Waye. Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update. International Journal of Molecular Sciences 2017; 18(11) doi: 10.3390/ijms18112423
|
| 58 |
Sulieman Ibraheem Shelash Al-Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, Nataliya S. Gilmanova, Hashem O. Alsaab, Adel Alghamdi, Shakeel Ahmed Ansari, Ahmed Hussien Radie Alawady, Ali Hashiem Alsaalamy, Ahmed Jaber Ibrahim. Breast cancer vaccines; A comprehensive and updated review. Pathology - Research and Practice 2023; 249 doi: 10.1016/j.prp.2023.154735
|
| 59 |
Mah Noor Zafar, William G. Pitt, Ghaleb A. Husseini. Encapsulation and release of calcein from herceptin-conjugated eLiposomes. Heliyon 2024; 10(6) doi: 10.1016/j.heliyon.2024.e27882
|
| 60 |
Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Durgaramani Sivadasan, Saad S. Alqahtani, Geeta Aggarwal. A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1149554
|
| 61 |
N A Saeed, I H Hamzah, S I Mahmood. The applications of nano-medicine in the breast cancer therapy. Journal of Physics: Conference Series 2021; 1853(1) doi: 10.1088/1742-6596/1853/1/012061
|
| 62 |
Sarah Asemota, Wendy Effah, Jeremiah Holt, Daniel Johnson, Linnea Cripe, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Yekta Khosrosereshki, Dong-Jin Hwang, Yali He, Brandy Grimes, Martin D. Fleming, Frances E. Pritchard, Ashley Hendrix, Meiyun Fan, Abhinav Jain, Hyo Young Choi, Liza Makowski, D. Neil Hayes, Duane D. Miller, Lawrence M. Pfeffer, Balaji Santhanam, Ramesh Narayanan. A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity. Proceedings of the National Academy of Sciences 2024; 121(40) doi: 10.1073/pnas.2406837121
|
| 63 |
Elena-Georgiana Dobre, Sorina Dinescu, Marieta Costache. Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer. Cancers 2020; 12(9) doi: 10.3390/cancers12092698
|
| 64 |
Nam Ho Jeoung, Ae Lim Jo, Hee Sung Park. Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells. Biochemical and Biophysical Research Communications 2021; 558 doi: 10.1016/j.bbrc.2021.04.054
|
| 65 |
Agata Binienda, Sylwia Ziolkowska, Elzbieta Pluciennik. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(15) doi: 10.2174/1871520620666191220142741
|
| 66 |
Steve Willy Tchabewu Mbianda, Nahit Rizaner, Ovgu Isbilen. Assessment of cytotoxic, anti-proliferative, anti-metastatic, and morphometric effects of Tecoma stans extracts against MDA-MB-231 human breast cancer cell line. BMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-025-04992-x
|
| 67 |
Marcella R. Cardoso, Alex Ap. Rosini Silva, Maria Cecília R. Talarico, Pedro H. Godoy Sanches, Maurício L. Sforça, Silvana A. Rocco, Luciana M. Rezende, Melissa Quintero, Tassia B. B. C. Costa, Laís R. Viana, Rafael R. Canevarolo, Amanda C. Ferracini, Susana Ramalho, Junier Marrero Gutierrez, Fernando Guimarães, Ljubica Tasic, Alessandra Tata, Luís O. Sarian, Leo L. Cheng, Andreia M. Porcari, Sophie F. M. Derchain. Metabolomics by NMR Combined with Machine Learning to Predict Neoadjuvant Chemotherapy Response for Breast Cancer. Cancers 2022; 14(20) doi: 10.3390/cancers14205055
|
| 68 |
Juan Li, Biao Xu, Qingwu Shi, Yizhen Deng, Yu Li, Wen Jin, Yanmei Zhu, Rongming Jiang, Suchen Qu, Linxin Teng, Chengyan Wu. CXCL9 as a key feature for deep learning-based immune subtyping and prediction of immune checkpoint blockade response in triple-negative breast cancer. International Immunopharmacology 2026; 175 doi: 10.1016/j.intimp.2026.116439
|
| 69 |
Marzia Deserti, Simone Sabbioni, Francesca Poli, Francesco Vasuri, Valeria Relli, Andrea Palloni, Chiara Deiana, Giovanni Brandi, Simona Tavolari. The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial–mesenchymal transition in triple-negative breast cancer cells. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1713273
|
| 70 |
Perrine Courlet, Evelina Cardoso, Carole Bandiera, Athina Stravodimou, Jean-Philippe Zurcher, Haithem Chtioui, Isabella Locatelli, Laurent Arthur Decosterd, Léa Darnaud, Benoit Blanchet, Jérôme Alexandre, Anna Dorothea Wagner, Khalil Zaman, Marie Paule Schneider, Monia Guidi, Chantal Csajka. Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer. Pharmaceutics 2022; 14(7) doi: 10.3390/pharmaceutics14071317
|
| 71 |
Melike Tepe, Şebnem Abadan, Mehmet F. Saglam, Veysel Süzerer, Pelin Balçık Erçin, Devrim Atilla, Esma Erciyas Baykal, Mine Gül Şeker, Tamer Yağcı, Yelda Özden Çiftçi. In vitro mass production, chemical modification, and cytotoxicity of shikonin derivatives on breast cancer cells. Industrial Crops and Products 2023; 192 doi: 10.1016/j.indcrop.2022.116087
|
| 72 |
Elda A. Flores-Contreras, Everardo Gonz醠ez-Gonz醠ez, Ana I. Zaraz鷄-Ni駉, Elsa N. Garza-Trevi駉, Natalia Mart韓ez-Acu馻, Viviana C. Zomosa-Signoret, Rom醤 Vidaltamayo, Gerardo E. Mu駉z-Maldonado, Raquel Garza-Guajardo, Manuel de J. Garc韆-Sol韘, Alejandro Abarca-Blanco, Ana M. G. Rivas-Estilla, Carlos C髍dova-Fletes. Overexpression of lnc-ERP44-3:6 Causes Cell Death and Sensitivity to Cisplatin in Breast Cancer Cell Lines. Oncologie 2021; 23(3) doi: 10.32604/oncologie.2021.017786
|
| 73 |
Edina H. Avdović, Žiko B. Milanović, Marko N. Živanović, Dragana S. Šeklić, Ivana D. Radojević, Ljiljana R. Čomić, Srećko R. Trifunović, Ana Amić, Zoran S. Marković. Synthesis, spectroscopic characterization, biological activity, DFT and molecular docking study of novel 4-hydroxycoumarine derivatives and corresponding palladium(II) complexes. Inorganica Chimica Acta 2020; 504 doi: 10.1016/j.ica.2020.119465
|
| 74 |
Pedram Ebrahimnejad, Zahra Mohammadi, Amirhossein Babaei, Melika Ahmadi, Shervin Amirkhanloo, Kofi Asare-Addo, Ali Nokhodchid.
Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications
. Critical Reviews™ in Therapeutic Drug Carrier Systems 2024; 41(1) doi: 10.1615/CritRevTherDrugCarrierSyst.v41.i1.20
|
| 75 |
Petros Papalexis, Vasiliki Georgakopoulou, Panagiotis Drossos, Eirini Thymara, Aphrodite Nonni, Andreas Lazaris, George Zografos, Demetrios Spandidos, Nikolaos Kavantzas, Georgia Eleni Thomopoulou. Precision medicine in breast cancer (Review). Molecular and Clinical Oncology 2024; 21(5) doi: 10.3892/mco.2024.2776
|
| 76 |
Arpita Pandey Tiwari, Sonali S. Rohiwal. Nanomedicines for Breast Cancer Theranostics. 2020; doi: 10.1016/B978-0-12-820016-2.00015-X
|
| 77 |
Mithua Ghosh, Sheela Mysore Lingaraju, Krishna C.R, Gautam Balaram, Ramya Kodandapani, Vijay E, Vijay K, Suhas N, Devika H, Shekar Patil, Satheesh Chiradoni Thungappa, Somorat Bhattacharjee, Sridhar P.S, Roshni Dasgupta, Mohammed Naseer, Srinivas B.J, Vishal Rao, Veena Ramaswamy, Radheshyam Naik, Govind Babu, Aarthi Ravichandran, Urvashi Bahadur, Krithika Murugan, Mahesh B, Lohith Reddy, Ajaikumar Basavalinga S. Comprehensive genomic profiling reveals a unique genomic landscape in solid tumors in an Indian cancer cohort of 1000 patients: a single institutional experience. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-94762-z
|
| 78 |
Venugopal R. Bovilla, Mahadevaswamy G. Kuruburu, Vidya G. Bettada, Jayashree Krishnamurthy, Olga A. Sukocheva, Rajesh K. Thimmulappa, Nanjunda Swamy Shivananju, Janardhan P. Balakrishna, SubbaRao V. Madhunapantula. Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo. Biomedicines 2021; 9(9) doi: 10.3390/biomedicines9091119
|
| 79 |
Sai Kiran S.S. Pindiprolu, Jitender Madhan, Dadi A. Srinivasarao, Nagasen Dasari, Chirravuri. S. Phani Kumar, Chantibabu Katta, Vaskuri G.S. Sainaga Jyothi. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer. Journal of Drug Delivery Science and Technology 2023; 86 doi: 10.1016/j.jddst.2023.104617
|
| 80 |
Hao Zhang, Ting Feng, Juntang Lin, Badrul Hisham Yahaya. Bibliometric-driven research on chemoresistance in breast cancer: knowledge mapping, hotspot evolution, and emerging insights (1994–2024). Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03542-8
|
| 81 |
Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, Ghazaleh Amjad, Mohammad Reza Ebadi, Ladan Younesi. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0725-6
|
| 82 |
Sina M. Matalqah, Khalid Aiedeh, Nizar M. Mhaidat, Karem H. Alzoubi, Belal A. AL-Husein. Preparation of Modified Chitosan-based Nanoparticles for Efficient
Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells. Current Cancer Drug Targets 2022; 22(2) doi: 10.2174/1568009622666220126100532
|
| 83 |
Nidhi Jyotsana, Zhenjiang Zhang, Lauren E. Himmel, Fang Yu, Michael R. King. Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection. Science Advances 2019; 5(7) doi: 10.1126/sciadv.aaw4197
|
| 84 |
Mohsen Salehi, Jafar Razmara, Shahriar Lotfi, Farnaz Mahan. A One-Dimensional Probabilistic Convolutional Neural Network for Prediction of Breast Cancer Survivability. The Computer Journal 2021; doi: 10.1093/comjnl/bxab096
|
| 85 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; doi: 10.1007/978-3-031-10839-6_2
|
| 86 |
Sumitha Elayaperumal, Yuvaraj Sivamani, Parth Agarwal, Nimmy Srivastava. Plant-based nanotherapeutics: A new frontier in disease management and prevention. Nano TransMed 2025; 4 doi: 10.1016/j.ntm.2025.100086
|
| 87 |
Mark Uhlik, Daniel Pointing, Seema Iyer, Luka Ausec, Miha Štajdohar, Robert Cvitkovič, Matjaž Žganec, Kerry Culm, Valerie Chamberlain Santos, Bronislaw Pytowski, Mokenge Malafa, Hong Liu, Arthur M. Krieg, Jeeyun Lee, Rafael Rosengarten, Laura Benjamin. Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1158345
|
| 88 |
Emmanuel Ifeanyi Obeagu. Hypoxia-inducible factors in breast cancer: prognostic indicators and emerging biomarkers: narrative review. Annals of Medicine & Surgery 2025; 87(9) doi: 10.1097/MS9.0000000000003500
|
| 89 |
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D. Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad, Prashant Kesharwani. Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of Controlled Release 2022; 341 doi: 10.1016/j.jconrel.2021.12.012
|
| 90 |
Nataliya Finiuk, Yuliia Kozak, Agnieszka Gornowicz, Robert Czarnomysy, Marlena Tynecka, Serhii Holota, Marcin Moniuszko, Rostyslav Stoika, Roman Lesyk, Krzysztof Bielawski, Anna Bielawska. The Proapoptotic Action of Pyrrolidinedione–Thiazolidinone Hybrids towards Human Breast Carcinoma Cells Does Not Depend on Their Genotype. Cancers 2024; 16(16) doi: 10.3390/cancers16162924
|
| 91 |
Nilesh Rai, Priyamvada Gupta, Ashish Verma, Santosh Kumar Singh, Vibhav Gautam. Isolation and characterization of N‐(2‐Hydroxyethyl)hexadecanamide from Colletotrichum gloeosporioides with apoptosis‐inducing potential in breast cancer cells. BioFactors 2023; 49(3) doi: 10.1002/biof.1940
|
| 92 |
Manoj Kumar Dash, Namrata Joshi, D.N.S Gautam, Remya Jayakumar, Y.B. Tripathi. Ayurvedic supportive therapy in the management of breast cancer. Journal of Herbal Medicine 2021; 29 doi: 10.1016/j.hermed.2021.100490
|
| 93 |
Ravichandran Vishwa, Bethsebie Lalduhsaki Sailo, Bandari BharathwajChetty, Mangala Hegde, Mohammed S. Alqahtani, Mohamed Abbas, Kwang Seok Ahn, Ajaikumar B. Kunnumakkara. Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence. Journal of Biochemical and Molecular Toxicology 2025; 39(11) doi: 10.1002/jbt.70557
|
| 94 |
Huma Hameed, Maham Afzal, Mahtab Ahmad Khan, Laiba Javaid, Maria Shahzad, Kamran Abrar. Unraveling the role of withanolides as key modulators in breast cancer mitigation. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10442-1
|
| 95 |
Mohammad Azam Ansari, Muthu Thiruvengadam, Zeba Farooqui, Govindaswamy Rajakumar, Qazi Mohammad Sajid Jamal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary, Ill-Min Chung, Ebtesam Abdullah Al-Suhaimi. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer. Seminars in Cancer Biology 2021; 69 doi: 10.1016/j.semcancer.2019.12.022
|
| 96 |
Claudia Rossi, Ilaria Cicalini, Maria Concetta Cufaro, Ada Consalvo, Prabin Upadhyaya, Gianluca Sala, Ivana Antonucci, Piero Del Boccio, Liborio Stuppia, Vincenzo De Laurenzi. Breast cancer in the era of integrating “Omics” approaches. Oncogenesis 2022; 11(1) doi: 10.1038/s41389-022-00393-8
|
| 97 |
Kitti Andreidesz, Aliz Szabo, Dominika Kovacs, Balazs Koszegi, Viola Bagone Vantus, Eszter Vamos, Mostafa Isbera, Tamas Kalai, Zita Bognar, Krisztina Kovacs, Ferenc Gallyas. Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines. International Journal of Molecular Sciences 2021; 22(16) doi: 10.3390/ijms22169016
|
| 98 |
Hilda Amekyeh, Enas Alkhader, Rayan Sabra, Nashiru Billa. Prospects of Curcumin Nanoformulations in Cancer Management. Molecules 2022; 27(2) doi: 10.3390/molecules27020361
|
| 99 |
Kitti Andreidesz, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas, Krisztina Kovacs. Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22042056
|
| 100 |
Evgenii L. Guryev, Natalia O. Volodina, Natalia Y. Shilyagina, Sergey V. Gudkov, Irina V. Balalaeva, Arthur B. Volovetskiy, Alexander V. Lyubeshkin, Alexey V. Sen’, Sergey A. Ermilov, Vladimir A. Vodeneev, Rem V. Petrov, Andrei V. Zvyagin, Zhores I. Alferov, Sergey M. Deyev.
Radioactive (
90
Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer
. Proceedings of the National Academy of Sciences 2018; 115(39) doi: 10.1073/pnas.1809258115
|
| 101 |
Jac A. Nickoloff, Aruna S. Jaiswal, Neelam Sharma, Elizabeth A. Williamson, Manh T. Tran, Dominic Arris, Ming Yang, Robert Hromas. Cellular Responses to Widespread DNA Replication Stress. International Journal of Molecular Sciences 2023; 24(23) doi: 10.3390/ijms242316903
|
| 102 |
Sufia Islam, Nazia Hoque, Nishat Nasrin, Mehnaz Hossain, Farhana Rizwan, Kushal Biswas, Muhammad Asaduzzaman, Sabera Rahman, David W. Hoskin, Saki Sultana, Christian Lehmann. Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach. Life 2022; 12(7) doi: 10.3390/life12070963
|
| 103 |
Anna Barkovskaya, Kotryna Seip, Lina Prasmickaite, Ian G. Mills, Siver A. Moestue, Harri M. Itkonen. Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74083-z
|
| 104 |
Bing Wang, Yueping Wang, Xuedong Wang, Juan Gu, Wenyong Wu, Huaiguo Wu, Qingping Wang, Daoping Zhou, Rohit Gundamaraju. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway. Disease Markers 2022; 2022 doi: 10.1155/2022/5762686
|
| 105 |
Baranya Murugan, Uma Maheswari Krishnan. Differently Sized Drug-Loaded Mesoporous Silica Nanoparticles Elicit Differential Gene Expression in MCF-7 Cancer Cells. Nanomedicine 2021; 16(12) doi: 10.2217/nnm-2020-0375
|
| 106 |
Zineb Habdoudou, Ikram Tiabi, Moulay Mustapha Ennaji. Cancer Biomarkers and Oncoviruses. 2026; doi: 10.1016/B978-0-443-30225-1.00020-8
|
| 107 |
Anastasia Murtha-Lemekhova, Juri Fuchs, Erik Schulz, Anthe Suzan Sterkenburg, Philipp Mayer, Jan Pfeiffenberger, Katrin Hoffmann. Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S328198
|
| 108 |
Yazan R. Alhamdan, Nehad M. Ayoub, Sara K. Jaradat, Aymen Shatnawi, Rami J. Yaghan, Sourav Panja. BRAF Expression and Copy Number Alterations Predict Unfavorable Tumor Features and Adverse Outcomes in Patients With Breast Cancer. International Journal of Breast Cancer 2024; 2024 doi: 10.1155/2024/6373900
|
| 109 |
Sarvesh Kumar Verma, Arpon Biswas, Mukesh Kumar, Anjali Mishra, Abhijit Deb Choudhury, Sristi Agrawal, Sachin Nashik Sanap, Amol Chhatrapati Bisen, Ashok Kumar Sharma, Gautam Panda, Rabi Sankar Bhatta. Preclinical pharmacokinetics, CYP phenotyping, and tissue distribution study of novel anti-breast cancer candidate S-011-1559. Xenobiotica 2022; 52(5) doi: 10.1080/00498254.2022.2101033
|
| 110 |
Lara Pierantoni, Virginia Brancato, João B. Costa, Subhas C. Kundu, Rui L. Reis, Joana Silva‐Correia, Joaquim M. Oliveira. Synergistic Effect of Co‐Culturing Breast Cancer Cells and Fibroblasts in the Formation of Tumoroid Clusters and Design of In Vitro 3D Models for the Testing of Anticancer Agents. Advanced Biology 2023; 7(4) doi: 10.1002/adbi.202200141
|
| 111 |
Muqtada Shaikh, Gaurav Doshi. Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential. Medical Oncology 2024; 42(1) doi: 10.1007/s12032-024-02589-x
|
| 112 |
Darshika Pasi, Bijulal Aswathy, Mrinmoy Das, Piyush Agrawal. Breast cancer pathogenesis, diagnosis and treatment: a comprehensive review. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1773232
|
| 113 |
|
| 114 |
Nilesh Raghunath Khedkar, Alex Joseph, Milind Sindkhedkar. Design, synthesis, and characterization of 3-(2-(pyrimidin-5-yl)thiazol-4-yl)-1,2,4-oxadiazole derivatives: Anticancer and molecular docking investigations. Synthetic Communications 2024; 54(2) doi: 10.1080/00397911.2023.2287796
|
| 115 |
Shubhank Sherekar, Ganesh A. Viswanathan. Boolean dynamic modeling of cancer signaling networks: Prognosis, progression, and therapeutics. Computational and Systems Oncology 2021; 1(2) doi: 10.1002/cso2.1017
|
| 116 |
Shailendra Dwivedi, Ruchika Agrawal, Radhieka Misra, Saba Anjum, Sudhir Shyam Kushwaha, Hari Shanker Joshi, Sanjeev Misra, Surekha Kishore. Biotechnology in Healthcare. 2022; doi: 10.1016/B978-0-323-90042-3.00012-8
|
| 117 |
Yu. A. Shevchenko, M. S. Kuznetsova, A. A. Khristin, S. V. Sidorov, S. V. Sennikov. Modern breast cancer therapy: from tamoxifen to T-cell engineering. Siberian journal of oncology 2022; 21(5) doi: 10.21294/1814-4861-2022-21-5-109-122
|
| 118 |
Fernanda Malhão, Alice Ramos, Ana Macedo, Eduardo Rocha. Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3D. Toxics 2021; 9(2) doi: 10.3390/toxics9020024
|
| 119 |
Farnaz Khodabakhsh, Shima Shokri, Neda Jalili, Shima Moradi-Kalbolandi, Fariba Dashtestani, Leila Farahmand. Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell lines. Chemical Papers 2023; 77(4) doi: 10.1007/s11696-022-02625-y
|
| 120 |
Emmanuel I. Obeagu. C-MPL signaling in breast cancer: molecular mechanisms and therapeutic implications. Annals of Medicine & Surgery 2026; 88(5) doi: 10.1097/MS9.0000000000004894
|
| 121 |
Mohammad Sadegh Taghizadeh, Ali Niazi, Ali Moghadam, Alireza Afsharifar, Jie Zheng. Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer. PLOS ONE 2022; 17(5) doi: 10.1371/journal.pone.0267961
|
| 122 |
Nilofer Shaikh, Sanket Bapat, Muthukumarasamy Karthikeyan, Renu Vyas. A Review on Computational Analysis of Big Data in Breast Cancer for Predicting Potential Biomarkers. Current Topics in Medicinal Chemistry 2022; 22(21) doi: 10.2174/1568026622666220907121942
|
| 123 |
Akanksha Behl, Zahoor A. Wani, Nagendra Nath Das, Virinder S. Parmar, Christophe Len, Shashwat Malhotra, Anil K. Chhillar. Monoclonal antibodies in breast cancer: A critical appraisal. Critical Reviews in Oncology/Hematology 2023; 183 doi: 10.1016/j.critrevonc.2023.103915
|
| 124 |
Nam Ji Sung, Na Hui Kim, Na Young Bae, Hyo Sik Jo, Sin-Aye Park. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20200164
|
| 125 |
David Enoma. Genomics in Clinical trials for Breast Cancer. Briefings in Functional Genomics 2024; 23(4) doi: 10.1093/bfgp/elad054
|
| 126 |
Md. Shalahuddin Millat, Md. Saddam Hussain, Arafat Miah, Md. Abdul Barek, Mohammad Sarowar Uddin, Mahmuda Ferdous, Md. Abdul Aziz, Md. Mahmudul Hoque, Md. Saiful Islam, Mohammad Safiqul Islam. Exploring the toxicity and clinical outcomes of doxorubicin, cyclophosphamide, and taxane-based chemotherapies in women with breast cancer in Bangladesh. Journal of Oncology Pharmacy Practice 2025; doi: 10.1177/10781552251377418
|
| 127 |
Alexander Atkins, Pratyush Gupta, Bing Melody Zhang, Wen-Sy Tsai, Julian Lucas, Manana Javey, Anagh Vora, Rui Mei. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection. Molecular Diagnosis & Therapy 2019; 23(4) doi: 10.1007/s40291-019-00406-0
|
| 128 |
Yuanyuan He, Raimundo Fernandes de Araújo Júnior, Rômulo S. Cavalcante, Zhenfeng Yu, Timo Schomann, Zili Gu, Christina Eich, Luis J. Cruz. Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles. Biomaterials Advances 2023; 145 doi: 10.1016/j.bioadv.2022.213270
|
| 129 |
Pang-Hung Hsu, Wei-Hsuan Chen, Chen Juan-Lu, Shu-Chen Hsieh, Shih-Chao Lin, Ru-Tsun Mai, Shiow-Yi Chen. Hesperidin and Chlorogenic Acid Synergistically Inhibit the Growth of Breast Cancer Cells via Estrogen Receptor/Mitochondrial Pathway. Life 2021; 11(9) doi: 10.3390/life11090950
|
| 130 |
Narendra Wajapeyee, Romi Gupta. Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies. Cancer Research 2021; 81(22) doi: 10.1158/0008-5472.CAN-21-1606
|
| 131 |
Khadijeh Moradi, Farnaz Barneh, Saeed Irian, Mohsen Amini, Raheleh Moradpoor, Amir Amanzadeh, Samira Choopani, Hamzeh Rahimi, Tayebeh Ghodselahi, Massoud M. Boujar, Mona Salimi. Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(8) doi: 10.2174/1871520619666190212123912
|
| 132 |
Kristina Witt, Maarten A. Ligtenberg, Laura Conti, Stefania Lanzardo, Roberto Ruiu, Tatjana Wallmann, Helena Tufvesson-Stiller, Benedict J. Chambers, Charlotte Rolny, Alvaro Lladser, Andreas Lundqvist, Federica Cavallo, Rolf Kiessling. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma. Cancer Immunology Research 2018; 6(11) doi: 10.1158/2326-6066.CIR-17-0572
|
| 133 |
|
| 134 |
Epigenetic Regulation of Cancer - Part A. International Review of Cell and Molecular Biology 2023; 380 doi: 10.1016/bs.ircmb.2023.04.002
|
| 135 |
A. P. L. Sabino, L. M. S. Eustáquio, A. C. F. Miranda, C. Biojone, T. N. Mariosa, Cibele Marli Cação Paiva Gouvêa.
Stryphnodendron adstringens (“Barbatimão”) Leaf Fraction: Chemical Characterization, Antioxidant Activity, and Cytotoxicity Towards Human Breast Cancer Cell Lines. Applied Biochemistry and Biotechnology 2018; 184(4) doi: 10.1007/s12010-017-2632-z
|
| 136 |
Mandana T. Manzari, Yosi Shamay, Hiroto Kiguchi, Neal Rosen, Maurizio Scaltriti, Daniel A. Heller. Targeted drug delivery strategies for precision medicines. Nature Reviews Materials 2021; 6(4) doi: 10.1038/s41578-020-00269-6
|
| 137 |
Michele Massimino, Paolo Vigneri, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Laura Nunziatina Parrinello, Calogero Vetro, Livia Manzella, Fabio Stagno, Francesco Di Raimondo. Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells. Journal of Clinical Medicine 2021; 10(23) doi: 10.3390/jcm10235606
|
| 138 |
Chang Yang, Yu Jiang, Sai Heng Hao, Xing Yi Yan, De Fei Hong, Hua Naranmandura. Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy. Journal of Materials Chemistry B 2022; 10(1) doi: 10.1039/D1TB02098F
|
| 139 |
Juan Jin, Zijia Sun, Fang Yang, Lin Tang, Weiwei Chen, Xiaoxiang Guan. miR-19b-3p inhibits breast cancer cell proliferation and reverses saracatinib-resistance by regulating PI3K/Akt pathway. Archives of Biochemistry and Biophysics 2018; 645 doi: 10.1016/j.abb.2018.03.015
|
| 140 |
Sushma Yadav, Claudia M. Kowolik, Daniel Schmolze, Yuan Yuan, Min Lin, Arthur D. Riggs, David A. Horne. Association of Structural Maintenance of Chromosome-1A Phosphorylation with Progression of Breast Cancer. Cells 2025; 14(2) doi: 10.3390/cells14020128
|
| 141 |
Sina Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, Sara Mehri, Shima Ababzadeh, Maria Kavianpour. Novel strategies in breast cancer management: From treatment to long-term remission. Critical Reviews in Oncology/Hematology 2025; 211 doi: 10.1016/j.critrevonc.2025.104715
|
| 142 |
Lingyuan Ma, Chenyu Li, Hanlin Yin, Jiashu Huang, Shenghao Yu, Jin Zhao, Yongxu Tang, Min Yu, Jie Lin, Lei Ding, Qinghua Cui. The Mechanism of DNA Methylation and miRNA in Breast Cancer. International Journal of Molecular Sciences 2023; 24(11) doi: 10.3390/ijms24119360
|
| 143 |
Anupriya Eswaran, Srinivasa Rao Sirasanagandla, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman. Therapeutic Potential of Alkaloids to Combat Breast Cancer: A Mechanistic Overview. Current Bioactive Compounds 2025; 21(10) doi: 10.2174/0115734072331654241211032635
|
| 144 |
Pratik Chakraborty, Hiranmoy Bhattacharya, Saikat Dewanjee. Nanotechnology-based immunotherapy, an emerging paradigm in breast cancer therapeutics. International Immunopharmacology 2025; 167 doi: 10.1016/j.intimp.2025.115728
|
| 145 |
Alaa Mohamed Maria, Mohamed El-Shebiney, Ayman Mohamed El-Saka, Yomna Zamzam. Expression of truncated HER2 and its prognostic value in HER2-positive breast cancer patients. Journal of the Egyptian National Cancer Institute 2018; 30(2) doi: 10.1016/j.jnci.2018.05.001
|
| 146 |
Stella D’Oronzo, Domenica Lovero, Raffaele Palmirotta, Luigia Stefania Stucci, Marco Tucci, Claudia Felici, Eliano Cascardi, Carmela Giardina, Paola Cafforio, Franco Silvestris. Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53660-x
|
| 147 |
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe, Mayur B Wanjari. Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive Review. Cureus 2023; doi: 10.7759/cureus.41737
|
| 148 |
Syazalina Zahari, Saiful Effendi Syafruddin, M. Aiman Mohtar. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression. Cancers 2023; 15(9) doi: 10.3390/cancers15092653
|
| 149 |
Navya Ajitkumar Bhaskaran, Naga Thirumalesh Chevala, Lalit Kumar. Nanomedicines for Breast Cancer Theranostics. 2020; doi: 10.1016/B978-0-12-820016-2.00011-2
|
| 150 |
Alexandre Holzbach Júnior, Bernardo Perin Cima, Mari Dalva Staffen, Juliana Dal-Ri Lindenau, Yara Costa Netto Muniz. A Review and Meta-analysis on Trastuzumab Resistance in Patients with
HER2+ Breast Cancer. Mini-Reviews in Medicinal Chemistry 2023; 23(11) doi: 10.2174/1389557523666230224110738
|
| 151 |
Komang Suma Triyasa, Ajeng Diantini, Melisa Intan Barliana. A Review of Herbal Medicine-Based Phytochemical of Garcinia as Molecular Therapy for Breast Cancer. Drug Design, Development and Therapy 2022; doi: 10.2147/DDDT.S358229
|
| 152 |
Henan Zhao, Duojiao Li, Baojing Zhang, Yan Qi, Yunpeng Diao, Yuhong Zhen, Xiaohong Shu. PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer. Molecules 2017; 22(12) doi: 10.3390/molecules22122277
|
| 153 |
Shiza Malik, Samra Khalid, Haidar Ali, Maham Khan, Faryal Mehwish, Aneela Javed, Fazal Akbar, Rumeza Hanif, Muhammad Suleman. In-silico modeling and analysis of the therapeutic potential of miRNA-7 on EGFR associated signaling network involved in breast cancer. Gene Reports 2020; 21 doi: 10.1016/j.genrep.2020.100938
|
| 154 |
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal, Ankur Vaidya. Nanotechnology Applications for Cancer Chemotherapy. 2021; doi: 10.1016/B978-0-12-817846-1.00016-3
|
| 155 |
Fan‐Wei Yang, Te‐Lun Mai, Ying‐Chung Jimmy Lin, Yu‐Chen Chen, Shang‐Che Kuo, Chia‐Ming Lin, Meng‐Hsuan Lee, Jung‐Chen Su. Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer. Archiv der Pharmazie 2024; 357(5) doi: 10.1002/ardp.202300435
|
| 156 |
Salma T. Rafik, Jayant S. Vaidya, Alexander J. MacRobert, Elnaz Yaghini. Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. Journal of Clinical Medicine 2023; 12(7) doi: 10.3390/jcm12072648
|
| 157 |
Andreea Crintea, Alina Gabriela Dutu, Gabriel Samasca, Ioan Alexandru Florian, Iulia Lupan, Alexandra Marioara Craciun. The Nanosystems Involved in Treating Lung Cancer. Life 2021; 11(7) doi: 10.3390/life11070682
|
| 158 |
Panchsheela Ubale, Santosh Mokale, Shweta More, Shailesh Waghamare, Vikramsinh More, Nethaji Munirathinam, Suma Dilipkumar, Rajesh Kumar Das, Sahin Reja, Vasant B Helavi, Shiva Prasad Kollur. Evaluation of in vitro anticancer, antimicrobial and antioxidant activities of new Cu(II) complexes derived from 4(3H)-quinazolinone: Synthesis, crystal structure and molecular docking studies. Journal of Molecular Structure 2022; 1251 doi: 10.1016/j.molstruc.2021.131984
|
| 159 |
Deeba Khan, Seema Shedole. Leveraging Deep Learning Techniques and Integrated Omics Data for Tailored Treatment of Breast Cancer. Journal of Personalized Medicine 2022; 12(5) doi: 10.3390/jpm12050674
|
| 160 |
A molecular screening of HER2 inhibitors from Curcuma zedoaria. THE 9TH INTERNATIONAL CONFERENCE OF THE INDONESIAN CHEMICAL SOCIETY ICICS 2021: Toward a Meaningful Society 2022; 2638 doi: 10.1063/5.0104024
|
| 161 |
Neville Murphy, Elan McCarthy, Róisín Dwyer, Pau Farràs. Boron clusters as breast cancer therapeutics. Journal of Inorganic Biochemistry 2021; 218 doi: 10.1016/j.jinorgbio.2021.111412
|
| 162 |
Benjamin Daniels, Federico Girosi, Hanna Tervonen, Belinda E. Kiely, Sarah J. Lord, Nehmat Houssami, Sallie-Anne Pearson, Aamir Ahmad. Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016). PLOS ONE 2018; 13(7) doi: 10.1371/journal.pone.0198152
|
| 163 |
Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu, Mahitosh Mandal. Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances. WIREs Nanomedicine and Nanobiotechnology 2023; 15(4) doi: 10.1002/wnan.1876
|
| 164 |
Rita Assi, Nuria Kotecki, Ahmad Awada. Targeting molecular subtypes in solid cancers: successes and failures. Current Opinion in Oncology 2020; 32(5) doi: 10.1097/CCO.0000000000000670
|
| 165 |
Anna Egorova, Ivan Pyankov, Marianna Maretina, Vladislav Baranov, Anton Kiselev. Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells. Pharmaceuticals 2021; 14(10) doi: 10.3390/ph14100957
|
| 166 |
Eduarda Carvalho, Sule Canberk, Fernando Schmitt, Nuno Vale. Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies. Cancers 2025; 17(7) doi: 10.3390/cancers17071102
|
| 167 |
Kristin Calar, Simona Plesselova, Somshuvra Bhattacharya, Megan Jorgensen, Pilar de la Puente. Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations. Cancers 2020; 12(7) doi: 10.3390/cancers12071722
|
| 168 |
Maryam Ahmadzadeh, Farzaneh Farshdari, Mahdi Behdani, Leila Nematollahi, Elham Mohit. Cloning, Expression and One-Step Purification of a Novel IP-10-(anti-HER2 scFv) Fusion Protein in Escherichia coli. International Journal of Peptide Research and Therapeutics 2021; 27(1) doi: 10.1007/s10989-020-10100-z
|
| 169 |
Imran Ahmad Khan, Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad. Benzimidazole. Biochemistry 2022; 34 doi: 10.5772/intechopen.101729
|
| 170 |
Hassan Yousefi, Afshin Bahramy, Narges Zafari, Mahsa Rostamian Delavar, Khoa Nguyen, Atousa Haghi, Tahmineh Kandelouei, Cecilia Vittori, Parham Jazireian, Sajad Maleki, Danyal Imani, Amin Moshksar, Amirreza Bitaraf, Sadegh Babashah. Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10383-z
|
| 171 |
Daniel Y. Lee, Arthur P. Staddon, Jacob E. Shabason, Ronnie Sebro. Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development. Cancer Medicine 2019; 8(2) doi: 10.1002/cam4.1958
|
| 172 |
Maryam Rashid, Ayesha Maqbool, Nusrat Shafiq, Yousef A. Bin Jardan, Shagufta Parveen, Mohammed Bourhia, Hiba-Allah Nafidi, Rashid Ahmed Khan. The combination of multi-approach studies to explore the potential therapeutic mechanisms of imidazole derivatives as an MCF-7 inhibitor in therapeutic strategies. Frontiers in Chemistry 2023; 11 doi: 10.3389/fchem.2023.1197665
|
| 173 |
Juan P. Muñoz, Pablo Pérez-Moreno, Yasmín Pérez, Gloria M. Calaf. The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application. Diagnostics 2023; 13(19) doi: 10.3390/diagnostics13193072
|
| 174 |
Yasmin M. Attia, Salama A. Salama, Samia A. Shouman, Cristina Ivan, Abdelrahman M. Elsayed, Paola Amero, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein. Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer. Pharmacological Reports 2022; 74(2) doi: 10.1007/s43440-021-00346-9
|
| 175 |
Narges Dastmalchi, Mohammad Ali Hosseinpourfeizi, Seyed Mahdi Banan Khojasteh, Behzad Baradaran, Reza Safaralizadeh. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Life Sciences 2020; 259 doi: 10.1016/j.lfs.2020.118239
|
| 176 |
Barbara Salvatore, Maria Grazia Caprio, Billy Samuel Hill, Annachiara Sarnella, Giovanni Nicola Roviello, Antonella Zannetti. Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer. Cancers 2019; 11(10) doi: 10.3390/cancers11101614
|
| 177 |
Violina T. Angelova, Teodora Tatarova, Rositsa Mihaylova, Nikolay Vassilev, Boris Petrov, Zvetanka Zhivkova, Irini Doytchinova. Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships. Molecules 2023; 28(5) doi: 10.3390/molecules28052058
|
| 178 |
Ghazal Mahmoudi, Yahya Ehteshaminia, Parviz Kokhaei, Seyedeh Farzaneh Jalali, Farhad Jadidi-Niaragh, Abdol Sattar Pagheh, Seyed Ehsan Enderami, Saeid Abedian Kenari, Hadi Hassannia. Enhancement of targeted therapy in combination with metformin on human breast cancer cell lines. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01446-0
|
| 179 |
Alisha Badal, Zelinda Engelbrecht, Marianne J. Cronjé. GAS5 as a therapeutic target in breast cancer through apoptosis induction. Cell Communication and Signaling 2025; 23(1) doi: 10.1186/s12964-025-02457-9
|
| 180 |
Quratulain Maqsood, Muhammad Umer Khan, Tehreem Fatima, Sania Khalid, Zaryab Ikram Malik. Recent Insights Into Breast Cancer: Molecular Pathways, Epigenetic Regulation, and Emerging Targeted Therapies. Breast Cancer: Basic and Clinical Research 2025; 19 doi: 10.1177/11782234251355663
|
| 181 |
Aviral Kumar, Dey Parama, Varsha Rana, Uzini Devi Daimary, Sosmitha Girisa, Ajaikumar B. Kunnumakkara. Molecular Biomarkers for Cancer Diagnosis and Therapy. 2024; doi: 10.1007/978-981-99-3746-2_28
|
| 182 |
Pei-Wei Shueng, Lu-Yi Yu, Hsiao-Hsin Hou, Hsin-Cheng Chiu, Chun-Liang Lo. Charge Conversion Polymer–Liposome Complexes to Overcome the Limitations of Cationic Liposomes in Mitochondrial-Targeting Drug Delivery. International Journal of Molecular Sciences 2022; 23(6) doi: 10.3390/ijms23063080
|
| 183 |
Ryan M. Ponec, Parvin Peddi, Rena D. Callahan. PARP Inhibitors in Breast Cancer: Latest Evidence. Current Breast Cancer Reports 2017; 9(3) doi: 10.1007/s12609-017-0251-x
|
| 184 |
Luca Andrei, Sandor Kasas, Ignacio Ochoa Garrido, Tijana Stanković, Mónica Suárez Korsnes, Radka Vaclavikova, Yehuda G. Assaraf, Milica Pešić. Advanced technological tools to study multidrug resistance in cancer. Drug Resistance Updates 2020; 48 doi: 10.1016/j.drup.2019.100658
|
| 185 |
Alqassem H. Abuarqoub, Waleed K. Abdulsahib, S. Renuka Jyothi, Priya Priyadarshini Nayak, Ashish Singh Chauhan, Siya Singla, Fadhil Faez Sead, Nodira Zakirova. Long non-coding RNAs and VEGF in ovarian cancer: mechanisms and therapeutic potential. Journal of Ovarian Research 2025; 19(1) doi: 10.1186/s13048-025-01909-7
|
| 186 |
Muttiah Barathan, Kumutha Malar Vellasamy, Vanitha Mariappan, Gopinath Venkatraman, Jamuna Vadivelu. Naturally Occurring Phytochemicals to Target Breast Cancer Cell Signaling. Applied Biochemistry and Biotechnology 2024; 196(7) doi: 10.1007/s12010-023-04734-0
|
| 187 |
Paramita Paul, Sanchita Mandal, Tarun Kumar Dua, Dipika Mandal, R Manasa Deepa. Multifunctional Theranostic Nanomedicines in Cancer. 2021; doi: 10.1016/B978-0-12-821712-2.00012-8
|
| 188 |
Mudasir Nabi Peerzada, Rania Hamdy, Masood Ahmad Rizvi, Saurabh Verma. Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor
Receptor 2 for Cancer Treatment. Current Pharmaceutical Design 2023; 29(44) doi: 10.2174/0113816128283615231218094706
|
| 189 |
Wieslawa H. Dragowska, Jagbir Singh, Mohamed Wehbe, Malathi Anantha, Katarina Edwards, Sharon M. Gorski, Marcel B. Bally, Ada W. Y. Leung. Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo. Pharmaceutics 2024; 17(1) doi: 10.3390/pharmaceutics17010042
|
| 190 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; doi: 10.1007/978-3-031-10839-6_4
|
| 191 |
Alyssa J. Wang, Caroline Hircock, Dominic Sferrazza, Ethan Goonaratne, David Cella, Andrew Bottomley, Shing Fung Lee, Adrian Chan, Edward Chow, Henry C. Y. Wong. The EORTC QLQ breast modules and the FACT-B for assessing quality of life in breast cancer patients – an updated literature review. Current Opinion in Supportive & Palliative Care 2024; 18(4) doi: 10.1097/SPC.0000000000000724
|
| 192 |
Balak Das Kurmi, Rishi Paliwal, Shivani Rai Paliwal. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach. International Journal of Biological Macromolecules 2020; 164 doi: 10.1016/j.ijbiomac.2020.08.172
|
| 193 |
Claudia Angélica Garay-Canales, Mariana Segovia-Mendoza, Yair Rodríguez-Santiago, Karen Elizabeth Nava-Castro, María del Sol Ríos-Avila, Guadalupe Esther Ángeles López, Valeria Vargas Ponce de León, Diana L. Ruiz-Antonio, César Antonio Zavala-López, Carmen T. Gómez de León, Jorge Morales-Montor. Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1735300
|
| 194 |
Mohammad Amin Tokallou, Mahmoud Mahmoudi, Ramiar Kamal Kheder, Seyedeh Fatemeh Azghadi, Ehsan Rastgoo, Abbas Sabouri, Seyed Alireza Esmaeili. Probiotics and the immune landscape: An ally in breast cancer combination therapy. Nutrition 2026; 143 doi: 10.1016/j.nut.2025.113011
|
| 195 |
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav. Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02111-9
|
| 196 |
Hangzhen Li, Jianlei Xiao, Xue Li, Qian Huang, Qingfeng Liu, Qing Zhang. Mechanism of morusin on breast cancer via network pharmacology and in vitro experiments. Medicine 2023; 102(28) doi: 10.1097/MD.0000000000034300
|
| 197 |
Alan Raj, Sarath Chandran C, Kamal Dua, Venkatesh Kamath, Angel Treasa Alex. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer. European Journal of Pharmacology 2024; 981 doi: 10.1016/j.ejphar.2024.176914
|
| 198 |
Prakash Bansode. Harnessing Medicinal Plants in Cancer Prevention and Treatment. Advances in Medical Diagnosis, Treatment, and Care 2024; doi: 10.4018/979-8-3693-1646-7.ch009
|
| 199 |
Prakash Bansode, Pradnya Patil, Prafulla Choudhari, Manish Bhatia, Apurva Birajdar, Indumathi Somasundaram, Gajanan Rashinkar. Anticancer activity and molecular docking studies of ferrocene tethered ionic liquids. Journal of Molecular Liquids 2019; 290 doi: 10.1016/j.molliq.2019.111182
|
| 200 |
Ubale Panchsheela Ashok, Shiva Prasad Kollur, Nishad Anil, Bansode Prakash Arun, Sanjay Namdev Jadhav, Sanjay Sarsamkar, Vasant Baburao Helavi, Asha Srinivasan, Sandeep Kaulage, Ravindra Veerapur, Sarah Al-Rashed, Asad Syed, Joaquín Ortega-Castro, Juan Frau, Norma Flores-Holguín, Daniel Glossman-Mitnik. Preparation, Spectroscopic Characterization, Theoretical Investigations, and In Vitro Anticancer Activity of Cd(II), Ni(II), Zn(II), and Cu(II) Complexes of 4(3H)-Quinazolinone-Derived Schiff Base. Molecules 2020; 25(24) doi: 10.3390/molecules25245973
|
| 201 |
Ritihaas Surya Challapalli, Roisin M. Dwyer, Niall McInerney, Michael J. Kerin, Aoife J. Lowery. Effect of Breast Cancer and Adjuvant Therapy on Adipose-Derived Stromal Cells: Implications for the Role of ADSCs in Regenerative Strategies for Breast Reconstruction. Stem Cell Reviews and Reports 2021; 17(2) doi: 10.1007/s12015-020-10038-1
|
| 202 |
Chandrabose Uthra, Karuppiah Nagaraj, Gangatharan Muralitharan, Mysoon M. Al-Ansari, Gunasekaran Velmurugan. Synthesis, characterization and apoptosis induction by cyanobacteria-derived neurotoxins: evaluating L-BMAA, 2,4-DAB, and AEG as potential anticancer agents against brain and breast cancer cells. Chemical Papers 2025; 79(12) doi: 10.1007/s11696-025-04364-2
|
| 203 |
Ishani D. Premaratne, Yoshiko Toyoda, Karel-Bart Celie, Kristy A. Brown, Jason A. Spector. Tissue Engineering Models for the Study of Breast Neoplastic Disease and the Tumor Microenvironment. Tissue Engineering Part B: Reviews 2020; 26(5) doi: 10.1089/ten.teb.2019.0347
|
| 204 |
Rui Wang, Yang Xuan, Yinan Zhao, Wei Wang, Pengfei Ma, Benzhi Ju, Yuhong Zhen, Shubiao Zhang. Cationic Nanoparticulate System for Codelivery of MicroRNA-424 and Podophyllotoxin as a Multimodal Anticancer Therapy. Molecular Pharmaceutics 2022; 19(7) doi: 10.1021/acs.molpharmaceut.1c00962
|
| 205 |
Hui-Yi Xue, Reina Bendayan, Ho-Lun Wong. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. 2020; doi: 10.1016/B978-0-12-816434-1.00005-X
|
| 206 |
Recapitulating the Stem Cell Niche Ex Vivo. Advances in Stem Cells and their Niches 2022; 6 doi: 10.1016/bs.asn.2022.02.001
|
| 207 |
Geetanjali Shinde, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule, Bhavana Shelke, Shalini Shinde. Molecular Docking, Drug likeness Studies and ADMET Prediction of Phytochemical of plant Ipomoea Tricolor for Breast Cancer Activity. Asian Journal of Pharmaceutical Research 2025; doi: 10.52711/2231-5691.2025.00016
|
| 208 |
Pooja Yadav, Srishty Jaiswal, Shourya Tripathi, Keerti Mishra, Rafquat Rana, Manish Kumar Chourasia. Innovative Targeting Strategies in Breast Cancer Therapy. 2026; doi: 10.1016/B978-0-443-33349-1.00004-1
|
| 209 |
Samah Hamed Almurisi, Goo Wei En, Muhamad Zakwan Hafiq, Leong Khai Sheng, Prasanthi Sri, Nadiatul Azra Binti Ahmad Mazlan, Payal Bhatnagar, Thiagarajan Madheswaran. Review of Lipid Nanoparticles for Breast Cancer Management: Targeting Strategies and Clinical Perspective. Current Nanomedicine 2026; 16(3) doi: 10.2174/0124681873326272241011161315
|
| 210 |
Jean-Lionel Bagot, Jean-Claude Karp, Véronique Lavallée, Isabelle Fischer, François Roux, Mariya Lilova, Lionel Uwer. Homeopathy, an interesting component of French integrative oncology: Examples of recommendations for use with new targeted breast cancer therapies. Hegel 2025; (2) doi: 10.3917/heg.152.0035
|
| 211 |
Mehdi Roshanian Bakhsh, Leila Rouhi, Kamran Ghaedi, Mehrdad Hashemi, Maryam Peymani, Saeed Samarghandian. Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 gene. Biomedicine & Pharmacotherapy 2023; 164 doi: 10.1016/j.biopha.2023.114982
|
| 212 |
Suhrit Dey, Charlie Dey. Mathematical and Computational Studies on Progress, Prognosis, Prevention and Panacea of Breast Cancer. Forum for Interdisciplinary Mathematics 2021; doi: 10.1007/978-981-16-6077-1_8
|
| 213 |
Chompunud Chompunud Na Ayudhya, Potchanapond Graidist, Varomyalin Tipmanee. Potential Stereoselective Binding of Trans-(±)-Kusunokinin and Cis-(±)-Kusunokinin Isomers to CSF1R. Molecules 2022; 27(13) doi: 10.3390/molecules27134194
|
| 214 |
Anna Maria Badowska-Kozakiewicz, Michał Piotr Budzik. Breast Cancer and Surgery. 2018; doi: 10.5772/intechopen.75354
|
| 215 |
Mohammed Moustapha Anwar, Manal Shalaby, Amira M. Embaby, Hesham Saeed, Mona M. Agwa, Ahmed Hussein. Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71157-w
|
| 216 |
Xiangyu Gao, Benjamin R. Caruso, Weimin Li. Advanced Hydrogels in Breast Cancer Therapy. Gels 2024; 10(7) doi: 10.3390/gels10070479
|
| 217 |
Makki Hussein Ali Alghnnami, Daryoush Hamidi Alamdari, Elnaz Haghighi, Mohsen Masoumian Hosseini, Niloufar Khatamian, Masoud Homayouni Tabrizi. Evaluate the effects of NLC lipid nanoparticles functionalized with a chitosan-folic acid-methylene blue conjugate on inducing apoptosis in breast cancer cells and inhibiting angiogenesis: An in silico and in vitro investigation. Results in Chemistry 2025; 18 doi: 10.1016/j.rechem.2025.102650
|
| 218 |
Ileana Castillo-Tobías, Lia Berlanga, Joan Poblano, María del C. Rodríguez-Salazar, Hilda Aguayo-Morales, Luis E. Cobos-Puc. Fundamental Considerations of Targeted Drug Therapies for Breast Cancer. Future Pharmacology 2023; 3(4) doi: 10.3390/futurepharmacol3040043
|
| 219 |
Meshack Bida, Benny Mosoane, Zukile Mbita, Demetra Demetriou, Thabiso Victor Miya, Lloyd Mabonga, Talent Chipiti, Zodwa Dlamini. Overcoming Breast Cancer Therapy Resistance. 2024; doi: 10.1007/978-3-031-52860-6_3
|
| 220 |
Yoser Al Rawi, Saima Shakil Malik, Nosheen Masood. Breast Cancer: From Bench to Personalized Medicine. 2022; doi: 10.1007/978-981-19-0197-3_16
|
| 221 |
Amna A. Saddiq, Ali H. El-Far, Shymaa A. Mohamed, Omar A. Almaghrabi, Shaker A. Mousa. Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines’ Progression. Integrative Cancer Therapies 2022; 21 doi: 10.1177/15347354221099537
|
| 222 |
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01805-y
|
| 223 |
Przemysław Borawski, Tomasz Sirek, Agata Sirek, Nikola Zmarzły, Robert Nowakowski, Piotr Ossowski, Michał Chalcarz, Kacper Boron, Dariusz Boron, Krzysztof Bereza, Konrad Dziobek, Nina Skalska-Dziobek, Piotr Wyrobiec, Beniamin Oskar Grabarek. Molecular crossroads: identifying MAPK proteins bridging SMAD and dopamine pathways in breast cancer. Cell Cycle 2025; 24(13-16) doi: 10.1080/15384101.2025.2549097
|
| 224 |
Sanjay Kulkarni, Soji Soman, Abhijeet Pandey, Srinivas Mutalik. Engineered transferrin-conjugated PEGylated multifunctional MOF-74 as precision nanotheranostics for triple-negative breast cancer. International Journal of Biological Macromolecules 2025; 322 doi: 10.1016/j.ijbiomac.2025.146857
|
| 225 |
Ming-Bo Huang, Purushottam B. Tiwari, Aykut Üren, Martin N. Shelton, Dara Brena, Jennifer Y. Wu, Mahfuz B. Khan, Michael D. Powell, Jonathan K. Stiles, Erica L. Johnson, Fengxia Yan, Lily Yang, Vincent C. Bond. Investigating SMR Peptide Interactions with Breast Cancer-Associated Proteins. International Journal of Molecular Sciences 2025; 26(18) doi: 10.3390/ijms26188848
|
| 226 |
Lisa Belfiore, Darren N. Saunders, Marie Ranson, Kristofer J. Thurecht, Gert Storm, Kara L. Vine. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities. Journal of Controlled Release 2018; 277 doi: 10.1016/j.jconrel.2018.02.040
|
| 227 |
Mi Li, Spiridon Tsavachidis, Fuchenchu Wang, Tuyen Bui, Tuyen Duong Thanh Nguyen, Linjie Luo, Asha S. Multani, Melissa L. Bondy, Kelly K. Hunt, Khandan Keyomarsi. Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer. Oncogene 2022; 41(50) doi: 10.1038/s41388-022-02527-z
|
| 228 |
Jeya Shree Thulasidas, Gowri Sree Varadarajan, Ignacio Camarillo, Lakshya Mittal, Raji Sundararajan. Efficacy of electrical pulse mediated tomato lipophilic extract on human breast cancer cell. Journal of Cancer Research and Therapeutics 2023; 19(Suppl 1) doi: 10.4103/jcrt.JCRT_1117_19
|
| 229 |
Zeyad Alehaideb, Saleh AlGhamdi, Wesam Bin Yahya, Hamad Al-Eidi, Mashael Alharbi, Monira Alaujan, Abeer Albaz, Muruj Tukruni, Atef Nehdi, Maha-Hamadien Abdulla, Sabine Matou-Nasri. Anti-Proliferative and Pro-Apoptotic Effects ofCalligonum comosum(L’Her.) Methanolic Extract in Human Triple-Negative MDA-MB-231 Breast Cancer Cells. Journal of Evidence-Based Integrative Medicine 2020; 25 doi: 10.1177/2515690X20978391
|
| 230 |
Arang Kwon, Hyun-Jung Park, Jeong-Hwa Baek. Beta-Catenin Downregulation Contributes to Epidermal Growth Factor-induced Migration and Invasion of MDAMB231 Cells. International Journal of Oral Biology 2018; 43(3) doi: 10.11620/IJOB.2018.43.3.161
|
| 231 |
Takeo Tatsuta. Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment. YAKUGAKU ZASSHI 2022; 142(10) doi: 10.1248/yakushi.22-00116
|
| 232 |
Deborah Obehi Onwusah, Elizabeth Bolanle Ojewole, Tawanda Manyangadze, Moses John Chimbari. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study. Patient Preference and Adherence 2023; doi: 10.2147/PPA.S416843
|
| 233 |
S. Sriharikrishnaa, Padmanaban S. Suresh, Shama Prasada K.. Optical Polarimetric Modalities for Biomedical Research. Biological and Medical Physics, Biomedical Engineering 2023; doi: 10.1007/978-3-031-31852-8_11
|
| 234 |
Yu Deng, Fulun Li, Pinglin He, Yafei Yang, Jin Yang, Yamei Zhang, Junying Liu, Yongping Tong, Qingfeng Li, Xian Mei, Zengyi Shu, Qi Zhao. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition. Molecular Carcinogenesis 2018; 57(6) doi: 10.1002/mc.22795
|
| 235 |
Zahra Tajik, Zahra Fazeli, Farkhondeh Pouresmaeili, Solat Eslami, Lobat Geranpayeh, Fatemeh Ghadyani, Soudeh Ghafouri-Fard. LINC00265 is significantly upregulated in breast carcinoma: expression, correlation networks, and potential prognostic value. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-11463-0
|
| 236 |
Wafaa S. Ramadan, Dana M. Zaher, Alaa M. Altaie, Iman M. Talaat, Adel Elmoselhi. Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms. International Journal of Molecular Sciences 2020; 21(2) doi: 10.3390/ijms21020565
|
| 237 |
Endale Hadgu, Daniel Seifu, Wondemagegnhu Tigneh, Yonas Bokretsion, Abebe Bekele, Markos Abebe, Thomas Sollie, Christina Karlsson, Mats G. Karlsson, Tomi F. Akinyemiju. Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study. PLOS ONE 2020; 15(5) doi: 10.1371/journal.pone.0232519
|
| 238 |
Megha Prem Paramban, Vishnu Asokan, M. V. Tintu, T. Ajayakumar. Clinicopathological Factors Predictive of Pathological Response and Impact on Disease-Free Survival in Breast Cancer. Journal of Radiation and Cancer Research 2022; 13(2) doi: 10.4103/jrcr.jrcr_54_21
|
| 239 |
Navid Mohammad Mirzaei, Sumeyye Su, Dilruba Sofia, Maura Hegarty, Mohamed H. Abdel-Rahman, Alireza Asadpoure, Colleen M. Cebulla, Young Hwan Chang, Wenrui Hao, Pamela R. Jackson, Adrian V. Lee, Daniel G. Stover, Zuzana Tatarova, Ioannis K. Zervantonakis, Leili Shahriyari. A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration. Journal of Personalized Medicine 2021; 11(10) doi: 10.3390/jpm11101031
|
| 240 |
Nuno Lopes, Viviana G. Correia, Angelina S. Palma, Catarina Brito. Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive Macrophages. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22041972
|
| 241 |
Busra Demir Cetinkaya, Cigir Biray Avci. Molecular perspective on targeted therapy in breast cancer: a review of current status. Medical Oncology 2022; 39(10) doi: 10.1007/s12032-022-01749-1
|
| 242 |
Reza Bozorgpour. From Molecules to Medicine: Molecular Dynamics and Docking in Breast Cancer Therapeutics. Clinical Breast Cancer 2025; 25(8) doi: 10.1016/j.clbc.2025.09.008
|
| 243 |
Jitender Singh, Pramod K. Avti, Krishan L. Khanduja, Divya Dahiya. Differential response of HER2 − and HER2 + breast cancer cells to quinazoline and triazole derivatives: advancing receptor subtype-specific phytochemical targeting. Molecular Diversity 2026; doi: 10.1007/s11030-026-11561-y
|
| 244 |
Shailima Rampogu, Thananjeyan Balasubramaniyam, Joon-Hwa Lee. Phytotherapeutic applications of alkaloids in treating breast cancer. Biomedicine & Pharmacotherapy 2022; 155 doi: 10.1016/j.biopha.2022.113760
|
| 245 |
Roshan Dutta, Praveen Guruvaiah, Kiran Kumar Reddi, Suresh Bugide, Dhana Sekhar Reddy Bandi, Yvonne J K Edwards, Kamaljeet Singh, Romi Gupta. UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress. NAR Cancer 2022; 4(4) doi: 10.1093/narcan/zcac035
|
| 246 |
Amir Soleimany, Delaram Kargari Aghmiouni, Masomeh Amirikhah, Mohammad Ali Shokrgozar, Sepideh Khoee, Bruno Sarmento. Two‐Photon Mediated Cancer Therapy: A Comprehensive Review on Two‐Photon Photodynamic Therapy and Two‐Photon‐Activated Therapeutic Delivery Systems. Advanced Functional Materials 2024; 34(48) doi: 10.1002/adfm.202408594
|
| 247 |
Huang Wei Ling. Chakras’ and energies deficiencies in the geneses of breast cancer. Obstetrics & Gynecology International Journal 2021; 12(2) doi: 10.15406/ogij.2021.12.00551
|
| 248 |
Sammed N. Mandape. Breast Cancer: Current Trends in Molecular Research. 2022; doi: 10.2174/9781681089522112010007
|
| 249 |
Mehdi Roshanian Bakhsh, Maryam Peymani, Leila Rouhi, Kamran Ghaedi.
PSAT1
gene as a biomarker for targeting triple negative breast cancer in presence of Rapamycin
. Nucleosides, Nucleotides & Nucleic Acids 2022; 41(2) doi: 10.1080/15257770.2021.2025393
|
| 250 |
Gabriel De la Cruz Ku, Manish Karamchandani, Diego Chambergo-Michilot, Alexis R. Narvaez-Rojas, Michael Jonczyk, Fortunato S. Príncipe-Meneses, David Posawatz, Salvatore Nardello, Abhishek Chatterjee. Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients. Annals of Surgical Oncology 2022; 29(10) doi: 10.1245/s10434-022-12133-8
|
| 251 |
Luis M. Ruiz-Manriquez, Cynthia Villarreal-Garza, Javier A. Benavides-Aguilar, Andrea Torres-Copado, José Isidoro-Sánchez, Carolina Estrada-Meza, María Goretti Arvizu-Espinosa, Sujay Paul, Raquel Cuevas-Diaz Duran. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms24129984
|
| 252 |
Zhaofu Tan, Hongbin Xin, Jian Chen, Ming Lei, Gang Tu, Lingfeng Tang. SIGLEC15 modulates the immunosuppressive microenvironment and suppresses malignant phenotypes in triple-negative breast cancer. Genes & Diseases 2026; 13(1) doi: 10.1016/j.gendis.2025.101799
|
| 253 |
Danesh Hassani, Mahmood Jeddi-Tehrani, Parisa Yousefi, Samaneh Mansouri-Fard, Maryam Mobini, Hengameh Ahmadi-Zare, Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Fazel Shokri. Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies. Cancer Chemotherapy and Pharmacology 2022; 89(3) doi: 10.1007/s00280-021-04390-3
|
| 254 |
Wahida Rahaman, Arabinda Chaudhuri. Self‐assembled Lipid Nanoparticles for Killing Triple Negative Breast Cancer Cells. Chemistry – An Asian Journal 2025; 20(1) doi: 10.1002/asia.202401049
|
| 255 |
Viswapriya Viswalingam, Dileep Kumar. Advancements in the Treatment and Prevention of Breast Cancer. 2026; doi: 10.1016/B978-0-443-33653-9.00014-4
|
| 256 |
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment. 2021; doi: 10.1007/978-3-030-68334-4_6
|
| 257 |
Tushar Singh Barwal, Uttam Sharma, Sonali Bazala, Ipsa Singh, Manju Jain, Hridayesh Prakash, Shashank Shekhar, Elise N. Sandberg, Anupam Bishayee, Aklank Jain. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084072
|
| 258 |
Isaac Shiri, Yazdan Salimi, Pooya Mohammadi Kazaj, Sara Bagherieh, Mehdi Amini, Abdollah Saberi Manesh, Habib Zaidi. Deep Radiogenomics Sequencing for Breast Tumor Gene-Phenotype Decoding Using Dynamic Contrast Magnetic Resonance Imaging. Molecular Imaging and Biology 2025; 27(1) doi: 10.1007/s11307-025-01981-x
|
| 259 |
Maarten van Eijk, René J. Boosman, Alfred H. Schinkel, Alwin D. R. Huitema, Jos H. Beijnen. Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes. Cancer Chemotherapy and Pharmacology 2019; 84(3) doi: 10.1007/s00280-019-03905-3
|
| 260 |
Dayanidhi Raman, Anca Maria Cimpean, Maria Rosaria De Miglio. Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1080684
|
| 261 |
Vaishali Kilor, Vipin Dhote, Nidhi Sapkal, Shagufta Khan. Nanotechnology Principles in Drug Targeting and Diagnosis. 2023; doi: 10.1016/B978-0-323-91763-6.00014-X
|
| 262 |
Jorge G.T. Zañudo, Steven N. Steinway, Réka Albert. Discrete dynamic network modeling of oncogenic signaling: Mechanistic insights for personalized treatment of cancer. Current Opinion in Systems Biology 2018; 9 doi: 10.1016/j.coisb.2018.02.002
|
| 263 |
Prakash Bansode, Dattaprasad Pore, Shivaji Tayade, Sandeep Patil, Prafulla Choudhari, Gajanan Rashinkar. Remarkable anti-breast cancer activity and molecular docking studies of ferrocene tethered pyrimidobenzothiazoles and pyrimidobenzimidazoles. Results in Chemistry 2023; 5 doi: 10.1016/j.rechem.2022.100758
|
| 264 |
Neelam Laxman Dashputre, Jayesh D. Kadam, Umesh D. Laddha, Surabhi B. Patil, Pavan B. Udavant, Smita P. Kakad. Targeting breast cancer using phytoconstituents: Nanomedicine-based drug delivery. European Journal of Medicinal Chemistry Reports 2023; 9 doi: 10.1016/j.ejmcr.2023.100116
|
| 265 |
Manzoor Ahmad Mir, Abrar Yousuf Mir. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. 2023; doi: 10.1007/978-981-19-8911-7_2
|
| 266 |
Isabel Monteiro, Samantha Morais, Ana Rute Costa, Luisa Lopes-Conceição, Natália Araújo, Filipa Fontes, Teresa Dias, Susana Pereira, Nuno Lunet. Changes in employment status up to 5 years after breast cancer diagnosis: A prospective cohort study. The Breast 2019; 48 doi: 10.1016/j.breast.2019.07.007
|
| 267 |
Shubhangi D. Shirsat, Vijaykumar V. Jadhav, Rajaram S. Mane. Nanomedicines for Breast Cancer Theranostics. 2020; doi: 10.1016/B978-0-12-820016-2.00003-3
|
| 268 |
|
| 269 |
Mário Esteves, Mariana P. Monteiro, José Alberto Duarte. The effects of vascularization on tumor development: A systematic review and meta-analysis of pre-clinical studies. Critical Reviews in Oncology/Hematology 2021; 159 doi: 10.1016/j.critrevonc.2021.103245
|
| 270 |
Nicola d'Avanzo, Giulia Torrieri, Patrícia Figueiredo, Christian Celia, Donatella Paolino, Alexandra Correia, Karina Moslova, Tambet Teesalu, Massimo Fresta, Hélder A. Santos. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy. International Journal of Pharmaceutics 2021; 597 doi: 10.1016/j.ijpharm.2021.120346
|
| 271 |
Nilofer Shaikh, Aruna Sivaram, Renu Vyas. Screening of natural product libraries in MCF7 cell line reveals the pro-apoptotic properties of β tetralone. Journal of Biomolecular Structure and Dynamics 2024; 42(2) doi: 10.1080/07391102.2023.2196697
|
| 272 |
Nehad M. Ayoub, Ghaith M. Al-Taani, Amer E. Alkhalifa, Dalia R. Ibrahim, Aymen Shatnawi, Guan-Jun Yang. The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset. The Breast Journal 2024; 2024 doi: 10.1155/2024/2582341
|
| 273 |
Rahamat Unissa Syed, Humera Banu, Alia Alshammrani, Maali D. Alshammari, Satheesh Kumar G, Kishore Kumar Kadimpati, Amna Abakar Suleiman Khalifa, Nayla Ahmed Mohammed Aboshouk, Aisha mofareh Almarir, Arshad Hussain, Farah Khaled Alahmed. MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunities. Pathology - Research and Practice 2024; 262 doi: 10.1016/j.prp.2024.155572
|
| 274 |
Hye Eun Park, Dohyun Han, Jae Seok Lee, Ilias P. Nikas, Hyeyoon Kim, Sohyeon Yang, Hyebin Lee, Han Suk Ryu. Comparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection. Pathobiology 2024; 91(5) doi: 10.1159/000539478
|
| 275 |
Chelsi James, Akeem Whitehead, Jasmine T. Plummer, Rory Thompson, Simone Badal. Failure to progress: breast and prostate cancer cell lines in developing targeted therapies. Cancer and Metastasis Reviews 2024; 43(4) doi: 10.1007/s10555-024-10202-w
|
| 276 |
Md. Anwarul Haque, Thanasis Poullikkas, F. M. Al-Amin Kaisar, Shariful Haque, Mst. Hajera Khatun, Al Mamun, Alam Khan. PHLPP1 depletion promotes tumorigenesis and stemness in triple-negative breast cancer cells through AKT signaling. Medical Oncology 2025; 42(3) doi: 10.1007/s12032-025-02630-7
|
| 277 |
Hanyi Fang, Alessandra Cavaliere, Ziqi Li, Yiyun Huang, Bernadette Marquez-Nostra. Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.627693
|
| 278 |
Stuti Roy, Suryendu Saha, Debanil Dhar, Puja Chakraborty, Kumar Singha Roy, Chitranjan Mukherjee, Arnab Gupta, Samir Bhattacharyya, Anup Roy, Sanghamitra Sengupta, Susanta Roychoudhury, Somsubhra Nath. Molecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancer. Cancer Gene Therapy 2022; 29(11) doi: 10.1038/s41417-022-00494-x
|
| 279 |
Deborah Kirk Walker, Lisa Whitehead. Breast surgery for metastatic breast cancer. British Journal of Community Nursing 2018; 23(7) doi: 10.12968/bjcn.2018.23.7.334
|
| 280 |
Dilipkumar Preetha, Iyyappan Saranya, Nagarajan Selvamurugan. Role of activating transcription factor 3 in breast cancer progression: Tumor suppressor and oncogene perspectives. Gene Reports 2025; 40 doi: 10.1016/j.genrep.2025.102284
|
| 281 |
Nasibeh Mohammad Ali Pourradi, Hossein Babaei, Hamed Hamishehkar, Behzad Baradaran, Behrooz Shokouhi-Gogani, Dariush Shanehbandi, Marjan Ghorbani, Yadollah Azarmi. Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer. Toxicology and Applied Pharmacology 2022; 446 doi: 10.1016/j.taap.2022.116036
|
| 282 |
Sanja Brnić, Bruno Špiljak, Lucija Zanze, Ema Barac, Robert Likić, Liborija Lugović-Mihić. Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review. Biomedicines 2025; 13(8) doi: 10.3390/biomedicines13081901
|
| 283 |
Gerson Ney Hernández-Acevedo, Angel Pulido-Capiz, Brenda Chimal-Vega, Victor García-González. Endoxifen Resistance in ER+ Breast Cancer Involves Translational Adaptation and Potential Contribution of ABCC Transporters. Future Pharmacology 2026; 6(2) doi: 10.3390/futurepharmacol6020024
|
| 284 |
Sneha Durgapal, Kent Hanson, Samantha K Kurosky, Sharon Kautz, Steve Sison, Christina Cool. Work productivity among patients with metastatic breast cancer in the United States. Expert Review of Pharmacoeconomics & Outcomes Research 2022; 22(7) doi: 10.1080/14737167.2022.2108409
|
| 285 |
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, Namdev Dhas. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review. Journal of Drug Delivery Science and Technology 2024; 100 doi: 10.1016/j.jddst.2024.106007
|
| 286 |
Ya-Ling Hsu, Meng-Chi Yen, Wei-An Chang, Pei-Hsun Tsai, Yi-Chung Pan, Ssu-Hui Liao, Po-Lin Kuo. CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB. Breast Cancer Research 2019; 21(1) doi: 10.1186/s13058-019-1114-3
|
| 287 |
Guillermo Valdivia, Ángela Alonso-Diez, Dolores Pérez-Alenza, Laura Peña. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review. Frontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.623800
|
| 288 |
Ferenc Gallyas, Fadi H. J. Ramadan, Kitti Andreidesz, Eniko Hocsak, Aliz Szabo, Antal Tapodi, Gyongyi N. Kiss, Katalin Fekete, Rita Bognar, Arpad Szanto, Zita Bognar. Involvement of Mitochondrial Mechanisms and Cyclooxygenase-2 Activation in the Effect of Desethylamiodarone on 4T1 Triple-Negative Breast Cancer Line. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031544
|
| 289 |
Isha Bansal, Amit Kumar Pandey, Munindra Ruwali. Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1244597
|
| 290 |
Ege Arzuk, Derviş Birim, Güliz Armağan. Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(11) doi: 10.1007/s00210-024-03286-2
|
| 291 |
Piotr Gierlich, Ana I. Mata, Claire Donohoe, Rui M. M. Brito, Mathias O. Senge, Lígia C. Gomes-da-Silva. Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment. Molecules 2020; 25(22) doi: 10.3390/molecules25225317
|
| 292 |
Riddhi Patel, Jenil Patel. Targeted Therapy for the Central Nervous System. 2025; doi: 10.1016/B978-0-443-23841-3.00013-3
|
| 293 |
Tayo A. Adekiya, Simeon K. Adesina. Leveraging Synergy: A Review of the Therapeutic Potential of SN-38 and Immune Checkpoint Blockade in Breast and Prostate Cancer Treatment. Journal of Personalized Medicine 2025; 15(11) doi: 10.3390/jpm15110512
|
| 294 |
Javad Mohammadi, Sina Ebrahimi, Maryam Ghodousi, Mohammadreza Mahmoodi, Ali Hheidari, Esmail Pishbin, Zelal Kharaba, Abbas Rahdar, Luiz Fernando Romanholo Ferreira. Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based breast cancer therapies. Journal of Drug Delivery Science and Technology 2024; 101 doi: 10.1016/j.jddst.2024.106249
|
| 295 |
Arpit Dave, Daniel Charytonowicz, Nancy J. Francoeur, Michael Beaumont, Kristin Beaumont, Hank Schmidt, Tizita Zeleke, Jose Silva, Robert Sebra. The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options. Cellular Oncology 2023; 46(3) doi: 10.1007/s13402-022-00765-7
|
| 296 |
Benita S. Katzenellenbogen, Valeria Sanabria Guillen, John A. Katzenellenbogen. Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer. Breast Cancer Research 2023; 25(1) doi: 10.1186/s13058-023-01675-8
|
| 297 |
Rizqah Kamies, Celia P. Martinez-Jimenez. Advances of single-cell genomics and epigenomics in human disease: where are we now?. Mammalian Genome 2020; 31(5-6) doi: 10.1007/s00335-020-09834-4
|